Dyne Therapeutics Inc Ordinary Shares DYN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
-
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
-
Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
-
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!
-
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!
-
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 152
- Website
- https://www.dyne-tx.com
Comparables
Valuation
|
Metric
|
DYN
|
CTNM
|
UTHR
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 15.15 |
Price/Book Value | 4.21 | 2.02 | 2.78 |
Price/Sales | — | — | 6.69 |
Price/Cash Flow | — | — | 14.35 |
Price/Earnings
DYN
CTNM
UTHR
Financial Strength
|
Metric
|
DYN
|
CTNM
|
UTHR
|
|---|---|---|---|
Quick Ratio | 26.18 | 58.48 | 3.92 |
Current Ratio | 26.63 | 58.92 | 4.35 |
Interest Coverage | — | — | 22.67 |
Quick Ratio
DYN
CTNM
UTHR
Profitability
|
Metric
|
DYN
|
CTNM
|
UTHR
|
|---|---|---|---|
Return on Assets (Normalized) | −55.93% | −18.15% | 16.95% |
Return on Equity (Normalized) | −64.68% | −871.68% | 20.53% |
Return on Invested Capital (Normalized) | −63.67% | −892.99% | 16.62% |
Return on Assets
DYN
CTNM
UTHR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Xvhlcnbhm | Ldjch | $512.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Txkjrzcn | Qgmzj | $117.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Hkrncdzk | Vdlgwq | $111.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Zldgyhxp | Jjhxdly | $34.4 Bil | |||
| argenx SE ADR
ARGX
| Tdjqccwk | Yqscx | $33.0 Bil | |||
| BioNTech SE ADR
BNTX
| Tlmgncct | Hsxm | $29.2 Bil | |||
| Moderna Inc
MRNA
| Qnycgysz | Krl | $23.1 Bil | |||
| United Therapeutics Corp
UTHR
| Kgldszcm | Rqjmj | $15.8 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Jgkzcltn | Wymvt | $13.2 Bil | |||
| Incyte Corp
INCY
| Njvnvfgv | Mkmffq | $13.0 Bil |
United States